Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes

被引:30
|
作者
Thorn, Lena M. [1 ,2 ,3 ,4 ]
Shams, Sara [5 ,6 ]
Gordin, Daniel [1 ,2 ,3 ,4 ,7 ]
Liebkind, Ron [8 ]
Forsblom, Carol [1 ,2 ,3 ,4 ]
Summanen, Paula [1 ,2 ,3 ,4 ,9 ]
Haegg-Holmberg, Stefanie [1 ,2 ,3 ,4 ]
Tatlisumak, Turgut [8 ,10 ,11 ]
Salonen, Oili [12 ]
Putaala, Jukka [8 ]
Martola, Juha [5 ,6 ,12 ]
Groop, Per-Henrik [1 ,2 ,3 ,4 ,13 ]
机构
[1] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[2] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland
[3] Helsinki Univ Hosp, Helsinki, Finland
[4] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland
[5] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden
[6] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[7] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA
[8] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland
[9] Helsinki Univ Hosp, Dept Ophthalmol, Helsinki, Finland
[10] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci Neurol, Gothenburg, Sweden
[11] Sahlgrenska Univs Hosp, Dept Neurol, Gothenburg, Sweden
[12] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland
[13] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
基金
芬兰科学院;
关键词
RISK-FACTORS; MICROBLEEDS; STROKE; RETINOPATHY; PREVALENCE;
D O I
10.2337/dc18-1302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVETo assess the prevalence of cerebral small-vessel disease (SVD) in subjects with type 1 diabetes compared with healthy control subjects and to characterize the diabetes-related factors associated with SVD.RESEARCH DESIGN AND METHODSThis substudy was cross-sectional in design and included 191 participants with type 1 diabetes and median age 40.0 years (interquartile range 33.0-45.1) and 30 healthy age- and sex-matched control subjects. All participants underwent clinical investigation and brain MRIs, assessed for cerebral SVD.RESULTSCerebral SVD was more common in participants with type 1 diabetes than in healthy control subjects: any marker 35% vs. 10% (P = 0.005), cerebral microbleeds (CMBs) 24% vs. 3.3% (P = 0.008), white matter hyperintensities 17% vs. 6.7% (P = 0.182), and lacunes 2.1% vs. 0% (P = 1.000). Presence of CMBs was independently associated with systolic blood pressure (odds ratio 1.03 [95% CI 1.00-1.05], P = 0.035).CONCLUSIONSCerebral SVD, CMBs in particular, is more common in young people with type 1 diabetes compared with healthy control subjects.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 50 条
  • [21] Depression in Adults with Type 1 Diabetes: The Role of Cerebral Small Vessel Disease
    Nunley, Karen A.
    Karp, Jordan F.
    Costacou, Tina
    Aizenstein, Howard J.
    Orchard, Trevor J.
    Rosano, Caterina
    DIABETES, 2017, 66 : LB61 - LB61
  • [22] Cerebral and Extracerebral Vasoreactivity in Patients With Different Clinical Manifestations of Cerebral Small-Vessel Disease: Data From the Significance of Hemodynamic and Hemostatic Factors in the Course of Different Manifestations of Cerebral Small-Vessel Disease Study
    Staszewski, Jacek
    Skrobowska, Ewa
    Piusinska-Macoch, Renata
    Brodacki, Bogdan
    Stepien, Adam
    JOURNAL OF ULTRASOUND IN MEDICINE, 2019, 38 (04) : 975 - 987
  • [23] The association between frailty and MRI features of cerebral small vessel disease
    Ilse M. J. Kant
    Henri J. M. M. Mutsaerts
    Simone J. T. van Montfort
    Myriam G. Jaarsma-Coes
    Theodoor D. Witkamp
    Georg Winterer
    Claudia D. Spies
    Jeroen Hendrikse
    Arjen J. C. Slooter
    Jeroen de Bresser
    Scientific Reports, 9
  • [24] The association between frailty and MRI features of cerebral small vessel disease
    Kant, Ilse M. J.
    Mutsaerts, Henri J. M. M.
    van Montfort, Simone J. T.
    Jaarsma-Coes, Myriam G.
    Witkamp, Theodoor D.
    Winterer, Georg
    Spies, Claudia D.
    Hendrikse, Jeroen
    Slooter, Arjen J. C.
    de Bresser, Jeroen
    Armbruster, Franz Paul
    Boecher, Axel
    Boraschi, Diana
    Borchers, Friedrich
    Della Camera, Giacomo
    van Delien, Edwin
    Diehl, Ina
    Dschietzig, Thomas Bernd
    Feinkohl, Insa
    Filmer, Ariane
    Gallinat, Juergen
    Hafen, Bettina
    Hartmann, Katarina
    Heidtke, Karsten
    Helmschrode, Anja
    Italiani, Paola
    Ittermann, Bernd
    Krause, Roland
    Kronabel, Marion
    Kuehn, Simone
    Lachmann, Gunnar
    Melillo, Daniela
    Menon, David K.
    Moreno-Lopez, Laura
    Moergeli, Rudolf
    Nuernberg, Peter
    Ofosu, Kwaku
    Olbert, Maria
    Pietzsch, Malte
    Pischon, Tobias
    Preller, Jacobus
    Ruppert, Jana
    Schneider, Reinhard
    Stamatakis, Emmanuel A.
    Weber, Simon
    Weyer, Marius
    Winzeck, Stefan
    Wolf, Alissa
    Yeurek, Fatima
    Zacharias, Norman
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [25] Clinical Features and Experimental Models of Cerebral Small Vessel Disease
    Shindo, Akihiro
    Ishikawa, Hidehiro
    Ii, Yuichiro
    Niwa, Atsushi
    Tomimoto, Hidekazu
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [26] The integrity of dynamic cerebral autoregulation in patients with small-vessel disease
    Bims, JM
    Markus, HS
    Kalra, L
    STROKE, 2005, 36 (02) : 517 - 517
  • [27] Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage
    Sato, Shoichiro
    Delcourt, Candice
    Heeley, Emma
    Arima, Hisatomi
    Zhang, Shihong
    Salman, Rustam Al-Shahi
    Stapf, Christian
    Woo, Daniel
    Flaherty, Matthew L.
    Vagal, Achala
    Levi, Christopher
    Davies, Leo
    Wang, Jiguang
    Robinson, Thompson
    Lavados, Pablo M.
    Lindley, Richard I.
    Chalmers, John
    Anderson, Craig S.
    STROKE, 2016, 47 (03) : 701 - 707
  • [28] Emerging insights from the genetics of cerebral small-vessel disease
    Rutten-Jacobs, Loes C. A.
    Rost, Natalia S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1471 (01) : 5 - 17
  • [29] Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease
    Peters, Nils
    MOLECULAR DIAGNOSIS & THERAPY, 2022, 26 (01) : 1 - 6
  • [30] C-reactive protein and cerebral small-vessel disease
    Schwandt, Peter
    FUTURE LIPIDOLOGY, 2006, 1 (01): : 9 - 11